Expression and prognostic significance of livin in the progression of bladder cancer

Abstract

It has been suggested that progression of bladder transitional cell cancer (BTCC) may be regulated at the molecular level by a typical pattern of expression of genes involved in apoptosis. Recently Livin, belonging to the inhibitors of apoptosis (IAP) family, has been found to be expressed in most solid tumors, where its expression is suggested to have clinical significance. In order to explore the significance of Livin expression in the development of BTCC, immunohistochemistry and RT-QPCR were used to detect the expression of Livin mRNA in tumor tissues and adjacent normal tissues of 30 cases of BTCC. The results showed that the positive rate of Livin expression in adjacent normal tissues and tumor tissues was 0 and 60% (18/30) respectively. The-ΔΔCT value of Livin in BTCC tissues was 8.0454 (7.4264–8.6644) times of that in adjacent normal tissues. The expression of Livin mRNA had no correlation with tumor pathological grades and clinical stages. It was suggested that there was weak expression of Livin mRNA in adjacent normal tissues, but strong in tumor tissues.

Keywords

Livin / bladder cancer / real-time quantitative PCR / immunohistochemistry

References

[1] OzenH., HallM. C.. Bladder cancer. Curr Opin Oncol, 2000, 12: 255-259

[2] SteinJ. P., GrossfeldG. D., GinsbergD. A., et al.. Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol, 1998, 160: 645-659

[3] LeeE., ParkI., LeeC.. Prognostic markers of intravesical bacillus Calmette-Guerìn therapy for multiple, high grade, stage T1 bladder cancer. Int J Urol, 1997, 4: 552-556

[4] KasofG. M., GomesB. C.. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem, 2001, 276: 3238-3246

[5] VucicD., StennickeH. R., PisabarroM. T., et al.. MLIAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol, 2000, 10: 1359-1366

[6] LinJ. H., DengG., HuangQ., et al.. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem Biophys Res Commun, 2000, 279: 820-831

[7] GazzanigaP., GradiloneA., GiulianiL., et al.. Expression and prognostic significance of Livin, SURVIVIN and other apoptosis related genes in the progression of superficial bladder cancer. Ann Oncol, 2003, 14: 85-90

[8] AltieriD. C.. Validating survivin as a cancer therapeutic target. Nat Rev Cancer, 2003, 3: 46-54

[9] SalvesenG. S., DuckettC. S.. IAP proteins: blocking the road to death’s door. Nat Rev Mol Cell Biol, 2002, 3: 401-410

[10] StrasserA., O’ConnorL., DixitV. M.. Apoptosis signaling. Annu Rev Biochem, 2000, 69: 217-245

[11] BortnerC. D., CidlowskiJ. A.. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol, 2002, 42: 259-281

[12] HuppertzB., FrankH. G., KingdomJ. C., et al.. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol, 1998, 110: 495-508

[13] RattsV. S., TaoX. J., WebsterC. B., et al.. Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta, 2000, 21: 361-366

[14] GruslinA., QiuQ., TsangB. K.. X-linked inhibitor of apoptosis protein expression and the regulation of apoptosis during human placental development. Biol Reprod, 2001, 64: 1264-1272